The country with the biggest weed habit? That might surprise you.

A new report claims the UK government should legalise marijuana because it's “the only solution to crime and addiction problems”.

The strongly-worded study - titled The Tide Effect: How the World is Changing its Mind on Cannabis - was produced by the nonpartisan Adam Smith Institute and has the backing of several cross-party MPs including former deputy prime minister, Nick Clegg.

Nutraceutical pain reliever makes use of marijuana’s CBD compound, doesn’t make you high.

Sales based on Israeli startup Lyotropic Delivery Systems (LDS) Biotech‘s nanotechnology have started in the US. The commercial launch of its cannabis-derived compound, which aims to relieve inflammation and pain, was announced earlier this month by LDS and US based company Ananda Scientific at a marijuana business conference held in Las Vegas.

Sales based on Israeli startup Lyotropic Delivery Systems (LDS) Biotech‘s nanotechnology have started in the US. The commercial launch of its cannabis-derived compound, which aims to relieve inflammation and pain, was announced earlier this month by LDS and US based company Ananda Scientific at a marijuana business conference held in Las Vegas.

A new report claims the UK government should legalise marijuana because it's “the only solution to crime and addiction problems”.

The strongly-worded study - titled The Tide Effect: How the World is Changing its Mind on Cannabis - was produced by the nonpartisan Adam Smith Institute and has the backing of several cross-party MPs including former deputy prime minister, Nick Clegg.

Tel Aviv-based Syqe Medical says its device revolutionizes precise delivery of the drug, already in use in Haifa hospital.

In a world first, Israel’s Teva Pharmaceutical Industries Ltd. and Tel Aviv-based Syqe Medical said they signed a distribution and cooperation agreement to market medical cannabis in an inhaler.

Under the agreement, Teva will be the exclusive marketer and distributor in Israel of an inhaler developed by Syqe Medical for the delivery of medical cannabis. The accord marks the first time that a major global pharma company has agreed to market a medical cannabis product, according to Syqe.

Although the United Nations international drug treaties have upheld an official prohibition against marijuana, the marijuana industry has spread across the Americas, Europe, and Asia.

As people are celebrating the legal sale of marijuana in the US, the burgeoning cannabis industry has gone from a curiosity to a bonafide booming market.

A new report by a leading marijuana industry investment and research firm found that legal cannabis sales jumped 17%, to $5.4 billion, in 2015 and they will grow by a whopping 25% this year to reach $6.7 billion in total US sales.

According to an INC.com report, there are also sizable and completely legal industries outside of the US, like Israel's 10-year-old medical industry. As governments from Germany to Australia to the UK are on the verge of legalising some form of marijuana, the global opportunity is coming into focus.

Yaakov Litzman voiced his support for cannabis exports, if the profits go directly to the Ministry of Health

Israel's Health Minister Yaakov Litzman of the ultra-Orthodox United Torah Judaism alliance on Sunday voiced his support for the Jewish State exporting medical marijuana- if the profits go directly to the Ministry of Health, Israel's Channel 2 news reports.

Speaking the Hamodia Economic Conference, organized by the ultra-Orthodox newspaper Hamodia, Litzman said that "I support the export of medical cannabis on the condition that the profits from the marijuana will go to the Health Ministry."

"This will most likely be approved," he added.

“People who don’t live severe autism can’t really understand what it means. It’s life in the shadow of hell,” says Israeli Abigail Dar, mother to 23 year old Yuval, who began showing signs of autism at the age of 18 months. 

Yuval is one of a growing number of children being diagnosed with autism, which according to the World Health Organization affects 1 in 160, a figure that rises to 1 in 68 in the United States.

Generally manifesting between 12 and 18 months, autism is characterised by difficulties in communication, an apparent inability to form human relationships, an unusually limited range of interests, and abnormal sensory issues. 

Tel Aviv, Israel-based Therapix BioSciences has filed for a modest $12 million initial public offering as it looks to build up its portfolio of cannabinoid-based meds.

The 12-year-old biotech is already listed on the Tel Aviv Stock Exchange and also trades on the over-the-counter (OTC) market in the U.S., but is now looking to step up and be listed on the Nasdaq, where its ticker will be $TRPX, according to Renaissance Capital.